Quarterly Updates12 May 2026, 05:31 pm
Neuland Labs: FY26 Results, ₹34 Dividend, New Director
AI Summary
Neuland Laboratories Ltd's board approved audited financial results for the year ended March 31, 2026, recommending a final dividend of ₹34 per equity share. They also appointed Dr. Mauricio Futran as an Additional Non-Executive Non-Independent Director, subject to shareholder approval. The 42nd AGM will be held on August 4, 2026, with a record date of July 24, 2026, for dividend eligibility. Additionally, the company approved a capacity enhancement at Unit 1 with an investment of ₹143.4 crores.
Key Highlights
- Approved audited financial results (standalone & consolidated) for FY26.
- Recommended final dividend of ₹34 (340%) per share for FY26.
- Appointed Dr. Mauricio Futran as Additional Non-Executive Non-Independent Director.
- Approved 42nd AGM on August 4, 2026; record date fixed as July 24, 2026.
- Approved capacity enhancement at Unit 1 with ₹143.4 crore investment.